Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by Tort Defenders’ writers and staff and is as accurate as possible. This content should not be taken as legal advice from an attorney.
Zepbound, a medication used to treat Type 2 diabetes and increasingly prescribed off-label for weight loss, has become the focus of a growing number of lawsuits. These lawsuits allege that Zepbound, like similar GLP-1 receptor agonists, can cause severe side effects that were not adequately disclosed by its manufacturer. As more patients come forward with claims of harm, it’s important to understand the details of the Zepbound lawsuits, the potential risks linked to this medication, and what this means for affected individuals.
What Is Zepbound?
Zepbound is a GLP-1 and GIP receptor agonist manufactured by Eli Lilly. It is primarily used for managing blood sugar levels in adults with Type 2 diabetes. Zepbound works by:
- Slowing digestion to reduce blood sugar spikes;
- Promoting insulin release to regulate glucose levels.
However, similar to drugs like Ozempic, Wegovy, and Mounjaro, Zepbound has also gained attention for its off-label use as a weight loss treatment. Its ability to suppress appetite and slow gastric emptying has made it popular among individuals seeking to lose significant weight.
While Zepbound offers promising benefits for diabetes management and weight loss, its use has raised concerns about severe side effects that some patients claim were not properly disclosed by the manufacturer.
Why Are People Filing Zepbound Lawsuits?
Failure to Warn of Severe Side Effects
Many plaintiffs claim that Eli Lilly failed to provide adequate warnings about the risks of using Zepbound, particularly for gastrointestinal issues. These include:
- Gastroparesis: A condition where the stomach is unable to empty food properly, leading to nausea, vomiting, and malnutrition.
- Severe Stomach Paralysis: Delayed gastric emptying can cause chronic and debilitating symptoms.
Some patients allege that they were not warned about these risks when prescribed Zepbound for diabetes or weight loss.
Misleading Marketing
The lawsuits also highlight concerns over the aggressive marketing of Zepbound for weight loss purposes, despite its approval being specifically for diabetes. Critics argue that:
- The medication was promoted to individuals who may not have been fully aware of the potential risks.
- Off-label use for weight loss has led to unintended consequences for patients without diabetes.
Long-Term Health Complications
Some plaintiffs report long-term complications after using Zepbound, particularly related to their digestive systems. These side effects can lead to reduced quality of life and significant medical expenses.
Common Side Effects Leading to Zepbound Lawsuits
Zepbound, like other GLP-1 medications, has been associated with severe gastrointestinal side effects that have significantly impacted patients’ lives. The most notable side effects mentioned in lawsuits include:
Gastroparesis (Stomach Paralysis)
- Gastroparesis occurs when the stomach muscles slow down or stop functioning, leading to delayed gastric emptying.
- Symptoms include persistent nausea, abdominal pain, bloating, and vomiting. In severe cases, patients may experience malnutrition and dehydration.
Ileus
- Ileus is a condition where the intestines stop functioning properly, causing a blockage that prevents food and fluids from moving through the digestive tract.
- Symptoms include abdominal swelling, severe constipation, and vomiting.
Intraoperative Pulmonary Aspiration
- Pulmonary aspiration occurs when stomach contents are inhaled into the lungs, often because of delayed gastric emptying.
- This can result in serious complications, including pneumonia, respiratory distress, and prolonged hospitalization.
Gallbladder Removal
- GLP-1 medications, including Zepbound, have been linked to gallbladder complications, such as gallstones and inflammation.
- In many cases, this has required surgical removal of the gallbladder to prevent further health issues.
Gastric Stasis and Chronic Vomiting
- Gastric stasis refers to the stomach’s inability to empty its contents properly, which can lead to prolonged symptoms of nausea, discomfort, and vomiting.
- Chronic vomiting, often reported by patients, can result in severe dehydration, electrolyte imbalances, and weight loss.
The Role of Off-Label Use in Zepbound Lawsuits
While Zepbound is FDA-approved for Type 2 diabetes management, it has increasingly been used off-label for weight loss. Off-label use refers to prescribing a medication for purposes other than its approved indication.
This trend mirrors the widespread off-label use of medications like Ozempic and Wegovy for weight loss. While many patients have experienced weight loss success, others have developed severe side effects they claim were not adequately disclosed.
Eli Lilly’s responsibility, as alleged in lawsuits, lies in ensuring that healthcare providers and patients understand the full range of risks—regardless of whether the medication is being used for diabetes or weight loss.
What the Zepbound Lawsuits Mean for Patients
If you or a loved one have experienced severe side effects while taking Zepbound, you may be wondering what the lawsuits mean for you. Here are the key points to consider:
Who Is Eligible to File a Lawsuit?
Individuals who experienced severe side effects, such as gastroparesis, pancreatitis, or chronic vomiting, after taking Zepbound may be eligible to file a lawsuit. Eligibility criteria typically include:
- Proof that you were prescribed Zepbound;
- Medical records documenting your condition and symptoms;
- Evidence of significant harm, such as hospitalization or long-term health issues.
Why Mass Tort Cases Are Likely
Zepbound lawsuits may become part of a mass tort litigation. In mass tort cases:
- Multiple plaintiffs with similar claims file lawsuits against the same defendant;
- Evidence, such as medical records and expert testimony, is shared across cases;
- Plaintiffs retain individual claims and compensation amounts based on their unique circumstances.
Mass tort litigation often provides a more efficient way for affected individuals to seek justice and compensation.
What to Do If You’ve Been Affected
If you believe you have suffered harm after taking Zepbound, here are the steps to take:
- Seek Medical Attention: If you’re experiencing severe side effects, consult with your healthcare provider immediately. Document all symptoms and treatments;
- Gather Evidence: Keep records of prescriptions, medical bills, and any communication with your doctor about Zepbound;
- Consult a Lawyer: Reach out to an attorney specializing in pharmaceutical lawsuits or mass tort cases. A qualified lawyer can evaluate your case and help you understand your legal options.
What’s Next for Zepbound Lawsuits?
The Zepbound lawsuits highlight growing concerns about the safety of GLP-1 receptor agonists, particularly as their off-label use for weight loss continues to rise. While Zepbound offers benefits for managing diabetes and aiding weight loss, the lawsuits allege that Eli Lilly failed to provide adequate warnings about the medication’s severe risks.
For patients who have experienced debilitating side effects like gastroparesis, pancreatitis, or persistent vomiting, these lawsuits represent an opportunity to seek compensation and hold the manufacturer accountable. As legal proceedings evolve, they may also lead to broader changes, such as clearer safety warnings and better monitoring of off-label drug use.If you or someone you know has been affected by Zepbound, it’s essential to take action. Seeking medical care, gathering evidence, and consulting with a knowledgeable attorney can help you protect your rights and pursue the compensation you deserve.